GlassScriptPhysician profile
Jon T Pope
NPI 1558022459
$461.05
in general payments reported to CMS, 2019-2025
10 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.93 · 2023: $249 · 2024: $68.02 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $132.52 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $98.78 | 2023 | Repatha |
| Boston Scientific Corporation | $89.53 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Terumo Medical Corporation | $28.21 | 2024 | Glidewire |
| Medtronic, INC. | $22.59 | 2025 | Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.33 | 2024 | Lifevest |
| Pfizer INC. | $19.48 | 2024 | |
| Bioxcel Therapeutics, INC. | $18.00 | 2023 | Igalmi |
| Daxor Corporation | $16.68 | 2025 | Bva-100 |
| Astrazeneca Pharmaceuticals LP | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.